Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00047983 · ClinicalTrials.gov registry record · Early Phase 1
Omega-3 Fatty Acids That Affect the Immune System in Kidney Transplant Patients
A Early Phase 1 study, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- Completed
- Registry status
- Early Phase 1
- Development phase
- 75
- Enrollment target
NCT00047983 is a Early Phase 1 study that has completed, run by National Institute of Allergy and Infectious Diseases (NIAID). The registered enrollment target is 75 participants.
The verdict
NCT00047983, a Early Phase 1 study, has completed, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 75 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the effectiveness of nutritional supplements in increasing the amount of omega-3 fatty acids (and arginine) in the red blood cell membranes and plasma of kidney transplant patients, and, secondarily, to compare patient compliance. The long-term goal of this study is to develop low risk therapies that will allow improved and lasting survival of donor tissue with minimal suppression of the immune system.
Interventions
- DIETARY_SUPPLEMENT Arginine
- DIETARY_SUPPLEMENT Canola oil
- DIETARY_SUPPLEMENT Fish oil emulsion
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Est. Completion | 2004-04 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00047983
The ClinicalTrials.gov registry entry for NCT00047983 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Arginine is the first listed.
NCT00047983 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00047983 about?
NCT00047983 is a clinical study titled "Omega-3 Fatty Acids That Affect the Immune System in Kidney Transplant Patients". The purpose of this study is to evaluate the effectiveness of nutritional supplements in increasing the amount of omega-3 fatty acids (and arginine) in the red blood cell membranes and plasma of kidney transplant patients, and, secondarily, to compare patient compliance. The long-term goal of this s...
What is the current status of trial NCT00047983?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 75 participants. Estimated completion is 2004-04.
What interventions are being tested in trial NCT00047983?
The interventions under investigation include: Arginine (DIETARY_SUPPLEMENT), Canola oil (DIETARY_SUPPLEMENT), Fish oil emulsion (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00047983?
This trial is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.